TRI-LUMA (fluocinolone acetonide; hydroquinone; tretinoin) Galderma labs lp Patent: 8,653,053 Expiration: Oct 25, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent …
Drug Patent Expirations for the Week of October 23, 2022 Read Post »
Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It is available from two suppliers. There are five patents protecting…
The post New patent expiration for Almatica drug GRALISE appeared first…
Annual Drug Patent Expirations for TRI-LUMA Tri-luma is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are four…
The post New patent expiration for Galderma Labs drug TRI-LUMA appeared first on …
New patent expiration for Galderma Labs drug TRI-LUMA Read Post »
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from one supplier.…
The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPatent…
Annual Drug Patent Expirations for SINGULAIR Singulair is a drug marketed by Organon and is included in three NDAs. There is one patent protecting this drug and two Paragraph IV…
The post New patent expiration for Organon drug SINGULAIR appeared first …
New patent expiration for Organon drug SINGULAIR Read Post »
Annual Drug Patent Expirations for HALFLYTELY Halflytely is a drug marketed by Braintree and is included in one NDA. There is one patent protecting this drug and two Paragraph IV…
The post New patent expiration for Braintree drug HALFLYTELY appeared fi…
New patent expiration for Braintree drug HALFLYTELY Read Post »
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Collegium Pharm drug NUCYNTA ER appeared fi…
New patent expiration for Collegium Pharm drug NUCYNTA ER Read Post »
SUMAVEL DOSEPRO (sumatriptan succinate) Endo ventures ltd Patent: 8,343,130 Expiration: Oct 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of October 16, 2022 Read Post »
Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in one NDA. There are nine patents protecting this drug. SUMAVEL…
The post New patent expiration for Endo Ventures drug SUMAVEL D…
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Redhill and is included in one NDA. It is available from three suppliers. There are six patents protecting…
The post New patent expiration for Redhill drug MOVANTIK appeared fir…